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2Abstract
Liposome is one of the most commonly used drug delivery systems in the world, due 
to its excellent biocompatibility, satisfactory ability in controlling drug release, and 
passive targeting capability. However, some drawbacks limit the application of 
liposomes in clinical, such as problems in transporting, storing, and difficulties in 
maintaining the drug concentration in the local area. Scaffolds usually are used as 
implants to supply certain mechanical supporting to the defective area or utilized as 
diagnosis and imaging methods. But, in general, unmodified scaffolds show limited 
abilities in promoting tissue regeneration and treating diseases. Therefore, 
liposome-scaffold composite systems are designed to take advantages of both 
liposomes’ biocompatibility and scaffolds’ strength to provide a novel system that is 
more suitable for clinical applications. This review introduces and discusses different 
types of liposomes and scaffolds, and also the application of liposome-scaffold 
composite systems in different diseases, such as cancer, diabetes, skin-related 
diseases, infection and human immunodeficiency virus, and in tissue regeneration 
like bone, teeth, spinal cord and wound healing. 
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31. Introduction 
Liposomes are closed vesicles with bilayer structure that is formed by dispersing 
amphipathic molecule, such as phospholipid, into water. Due to the hydrophobic tail 
and the hydrophilic head section, these tails tend to aggregate to avoid contacting 
with water and these heads are likely to expose to water[1]. The special bilayer 
structure makes these carriers can load hydrophilic drug in the internal water phase 
and the hydrophobic drug in the bilayer. 
In the early stage (1960), liposomes were regarded as a research model of cell 
membrane, while nowadays they are mainly used as drug carriers to deliver proteins, 
growth factors and other chemical drugs. As drug delivery carriers, liposomes have 
various advantages, such as (1) passive targeting via enhanced permeability and 
retention effect in tumor area, (2) excellent ability in controlling drug release, (3) 
decreased drug side effects, and (4) improved drug stability, which make them 
effective in delivering drugs, vaccines, imaging, cosmetics, etc.[2]. However, 
liposomes have also drawbacks that limit their clinical applications, such as (1) 
challenges in transporting liquid formulation, (2) insufficient mechanical properties, 
and (3) inability to maintain certain drug concentration in the local area. Therefore, 
certain improvements are needed to offer more suitable liposomes for clinical 
applications.
Tissue engineering, also known as regenerative medicine, aims to develop 
bioactive implants that can repair or ameliorate the structure and functionality of 
tissue defects. In tissue engineering, there are three critical elements, cells, scaffolds 
and bioactive factors[3]. Among them, scaffolds, which can diagnose, repair or 
improve the functionality in tissue and organ, are regarded as core materials and 
have attracted a considerable attention in research. Moreover, scaffolds can provide 
unique features that cannot be achieved by drugs [4], such as (1) provide certain 
mechanical supporting in defect areas, (2) stimulate cells’ differentiation by 
regulating the Youngs’ modulus, and (3) execute, raise or replace some lost functions 
caused by diseases or impairments. Scaffolds can provide mechanical support and 
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4appropriate environment for cell proliferation, and control the flow of blood or other 
body fluid, which functions as fillers. It is difficult to achieve the repairing goals in 
serious injuries portion or other clinical requirements when scaffolds are utilized 
without any drugs or cells. 
Recently, drug-loaded scaffolds were proved to have both therapeutic effects 
brought by drugs and mechanical support supplied by materials. However, these 
drug-loaded scaffolds still have some problems, e.g., (1) limited choices at drug 
types, (2) burst drug release, and (3) difficulty in maintaining certain drug 
concentration in local areas. Therefore, based on the advantages of liposomes (drug 
carriers) and the benefits of scaffolds (mechanical supporting), it is reasonable to 
believe that combining liposomes with scaffolds can help drugs maintain certain 
concentration in situ for a long period, and the composite systems can provide more 
functionalities. For example, liposomes-modified scaffolds have more choices at 
loaded drug types, and in addition, drugs carried in liposomes can provide the 
composite scaffold capabilities in promoting regeneration in defect areas. Moreover, 
controlled and responsive drug release in scaffolds can be achieved by using 
functional liposomes. 
Herein, this review introduces and discusses different types of liposomes and 
scaffolds, and also the application of liposome-scaffold composite systems in 
different diseases, such as cancer, diabetes, skin-related diseases, infection and 
human immunodeficiency virus, and in tissue regeneration like bone, teeth, spinal 
cord and wound healing. 
Liposomes 
In 1960s, Bangham[5] observed the specific behaviors of lipids by transmission 
electron microscope (TEM). When he dispersed lipids into water, he found a kind of 
vesicle filled with water in the inner core that was similar to the structure of cells. 
According to the images collected from the mixture of lipids and water, he named 
this kind of material as liposomes. The self-assembling core-shell vesicle structure 
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5enables liposomes to carry both hydrophobic and hydrophilic drugs, which is 
regarded as the most ancient nano-drug delivery system. Since the first liposomes 
were fabricated, researchers have done a series of investigations about the 
biophysical and biochemical properties of liposomes. For example, liposomes were 
utilized as a model to explore cell membranes, these nanoparticles were also used in 
the areas of drug delivery[6], diagnostics[7], imaging[8], food and cosmetic 
industries [9, 10], molecular biology[11], biochemistry[12], and microfluidics[13]. 
In this review, we will mainly focus on the drug delivery capability of liposomes 
and discuss the special functionalities and limitations in application. 
1.1 Drug-loaded liposomes
Liposomes have been widely investigated as drug carriers, from the approved 
amphotericin B liposome in 1990 to the successful Onivyde™ in 2015. As drug 
carriers, liposomes have several advantages, for instance, they can carry various 
types of drugs, specifically, the internal water core can load hydrophilic drugs and 
the bilayers can carry hydrophobic ones. Additionally, liposomes exhibit the ability in 
controlling the drug release and decreasing the side effect of drugs. Furthermore, 
liposomes also show advantages in low toxicity, non-immunogenic and 
biodegradability. The phospholipid bilayer can be regarded as satisfactory platforms 
that can be modified with diverse ligands to achieve the goal of targeting delivery. 
Furthermore, the stability and efficacy of biological products can also be improved 
by utilizing liposomes as vehicles. 
1.1.1 Delivering small molecule hydrophilic drugs
Several methods, such as reverse evaporation, pH gradient, ammonium sulfate 
gradient and repeated freeze thawing, are usually applied in the process of preparing 
small hydrophilic drugs-loaded liposomes. For example, Takeuchi et al.[14] 
fabricated polyborane encapsulated liposomes though pH gradient or reverse-phase 
evaporation, then they found that for the encapsulation efficiency of the liposome 
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6prepared using the pH gradient was twice as high as that prepared, using 
reverse-phase evaporation. Additionally, they observed that boron concentration of 
the polyborane encapsulated liposomes prepared using the pH gradient achieved 
110–150 μg/g of tumor tissue. 
1.1.2 Delivering small molecule hydrophobic drugs
Usually the film dispersion method is one of the simplest ways to fabricate lipid 
drug-loaded liposomes. For example, Fu et al.[15] fabricated novel 
temperature-sensitive liposomes loading paclitaxel (PTX-TSL) by using a film 
dispersion method. The encapsulation efficiency of K237-PTX-TSL was 94.23 
(± 0.76)%. The particle diameter was 88.3 ± 4.7 nm. Liao et al.[16] prepared Iridium 
(III) complex-loaded liposomes by thin-film dispersion and ultrasonic method. The 
average particle size, polydispersity index, zeta-potential, encapsulation efficiency, 
and drug loading are 112.57±1.15 nm, 0.19±0.02, −10.66±0.61 mV, 94.71 (±3.21)%, 
and 4.71(±0.41)%, respectively. 
1.1.3 Delivering gene drugs
As non-viral delivery system, one of the most popular functions of liposomes is 
transfection. By using tripeptide-based lipid (CDO) as a model lipid and sucrose 
esters (SEs) as helper lipids, a series of liposomes were prepared by Zhao et al.[17] 
The transfection efficiencies of the liposomes, containing SEs with hydrophilic–
lipophilic balance (HLB) value of 6 were superior to other liposomes in HeLa, MCF-7, 
NCI-H460, and A549 tumor cells.
1.1.4 Delivering growth factors 
Growth factors can regulate the cell behaviors. For example, keratinocyte growth 
factor (KGF) is effective to treat ulcerative colitis. But this growth factor fails to be 
stable and specific distribution toward inflamed bowel. Zhao et al.[18] fabricated 
KGF-loaded liposomes with a high encapsulation efficiency of 95.3 (± 0.72)%, PDI of 
0.18, and zeta-potential of −2.37 ± 0.14 mV.  
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71.1.5 Delivering proteins 
Comparing to small molecule drugs, proteins have more specific functions, higher 
bioactivity and lower toxicity, which is more beneficial for clinical applications. 
Liposomes have also been used for protein delivery. For example, Dapergolas et 
al.[19] fabricated insulin-loaded liposomes to treat diabetes rats. Yamada et al.[20] 
utilized liposomes to deliver coenzyme Q10 to improve its cellular uptake, which 
provides a novel strategy in treating mitochondria-related diseases.    
1.2 Functionalized liposomes 
1.2.1 Long circulating liposomes
Surface modification of the scaffold with polyethylene glycol (PEG), 
phosphatidylinositol (PI) or ganglioside can bring dense conformational cloud to the 
liposome systems. This three-dimensional conformation can protect liposomes from 
opsonin recognition in blood and reduce rapid phagocytosis or uptake in 
reticuloendothelial system. Therefore, the clearing rate of liposomes can be 
decreased in vivo and the circulation time in blood can be extended, leading to the 
prolong drug circulation in blood.[21] 
1.2.2 Thermosensitive liposomes
Typically, thermosensitive liposomes (TSL) consist of thermo-responsive materials, 
such as dipalmitoyl phosphatidylcholine (DPPC) and distearoyl phosphatidylcholine 
(DSPC), which can transform from a solid gel to a highly permeable liquid structure 
with increasing temperature. Usually, this kind of liposomes consist of special lipid 
materials with slightly higher phase transition temperature than the body 
temperature, and the drug release in this case is mediated by temperature[22, 23]. 
1.2.3 pH-Sensitive liposomes 
Some common pH-sensitive materials, such as dioleoyl phosphatidylethanolamine 
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8(DOPEA)[24, 25], N-(4-carboxybenzyl)-N,N-dimethyl-2,3-bis(oleoyloxy)propan-1- 
aminium (DOBAQ), are widely used in the fabrication of pH-responsive liposomes. 
For liposomes prepared with these materials, when the local area exhibits slightly 
acid pH (pH<6), the carboxyl in fatty acid is protonated, causing the formation of a 
hexagonal phase and the fusion between the cell membranes and liposomes, which 
benefits the intracellular drug delivery. The microenvironment in the tumor area is 
usually acid, additionally, acid pH-responsive liposomes have been widely 
investigated in targeting drug delivery for cancer therapy.
1.2.4 Magnetic liposomes 
During the process of liposome preparation, magnetic materials can be added to 
endow the system with magnetic response [26]. When these intelligent carriers are 
injected into body, the movement of these liposomes can be controlled by applied 
an external magnetic field to guide these nanoparticles to the local area. These 
vehicles are proved to improve the specificity of the therapy and the accuracy of 
diagnosis (e.g., by magnetic resonance imaging)[27]. Moreover, liposomes can also 
contain multifunction, including imaging, diagnosis to achieve high efficiency with 
low adverse effect [28, 29]. 
1.2.5 Active targeting liposomes 
Active targeting can be achieved by specific binding between receptors and ligands, 
ligands could be some common compounds, for example, antibodies, Fab fragments, 
DNA or RNA sequences, transferrin, and peptides. Generally, these ligands can be 
used to fabricate active targeting liposomes to get more efficient therapy. [30, 31]. 
1.3 Summary
As novel drug carriers, liposomes have achieved significant success in clinical 
applications, such as amphotericin B@liposome, doxorubicin@liposome, and 
daunorubicin@liposome. However, there are still some disadvantages in this drug 
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9delivery system, for example, the challenge in mass production, poor reproducibility, 
high production costs, the leakage of loading drugs, and the fusion among 
liposomes. These drawbacks largely limit the application of liposomes in clinic. 
2 Scaffolds for drug loading 
Currently, scaffolds are widely used for diagnosis, tissue regeneration and function 
restoration in some organs. Basically, there are mainly three types of scaffolds: metal 
scaffolds, such as alkali metal scaffolds and some alloy scaffolds; inorganic scaffolds, 
likes bioactive glass and hydroxyapatite; and organic scaffolds, e.g. polymeric based 
scaffolds. These scaffolds can supply necessary mechanical support to the local 
defect area and provide suitable microenvironment for cell proliferation, and these 
materials can also control the flow of blood and body fluid. However, scaffolds 
themselves have low therapeutic effect in local area, thus they cannot meet various 
demands in clinic. Therefore, fabricating drug-loaded scaffolds is necessary for 
expanding the scaffolds’ clinical applications. In this section we introduce different 
types of scaffolds and the method of drug-loading.
2.1. Metal scaffolds
As a result, of the excellent mechanical strength, toughness and anti-fatigue 
performance, metal scaffolds have been widely used in tissue engineering. For 
example, these metal materials have be used to repair or replace the lesioned or 
partly worn teeth[32], bones[33], joints or other tissues. These materials can also be 
regarded as cardiovascular stents[34, 35], artificial heart valve[36], etc. Moreover, 
these metal scaffolds can be produced in different shapes, such as needle, nail, 
intramedullary needle, crown, triangular nail[37], which is suitable for diverse 
applications in tissue engineering. 
The most common materials for making metal scaffolds include medical 
precious metals and their alloys, for example, gold, silver, platinum and their alloys, 
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medical stainless-steel[38], medical cobalt-based alloy[39], medical titanium alloy 
and medical titanium nickel alloy[40]. Some of these metals can be further modified 
to make them more functional. For example, Pan et al. [41] modified the surface of 
titanium implants by two mussel-derived bioactive peptides to achieve the goal of 
specific cell adhesion and osteogenicity. For these metal materials, the advantages 
to apply them in tissue regeneration are the efficiently mechanical strength 
supported by them, and the stable physicochemical properties. However, they also 
meet some challenges, for example, usually it is difficult to produce drug-loaded 
metal scaffolds. 
2.2. Inorganic scaffolds for drug loading 
Inorganic scaffolds own favorable biocompatibility, mechanical strength and can 
release some bioactive elements that are necessary in the process of regeneration, 
thus these scaffolds have been widely investigated. For example, bioactive glass is 
one type of inorganic scaffold that have been extensively utilized in promoting bone 
regeneration, because of their excellent biocompatibility, and potential ability in 
accelerating bone repairing[42], as shown in Figure 1. Hydroxyapatite is one of the 
most important complements in human bones. The hydroxyapatite based scaffold 
can not only supply certain mechanical support in the local area, but also constantly 
release some bioactive elements to the external environment, such as calcium, 
phosphorus, which are beneficial for tissue repair[43]. Bioinert ceramics like alumina 
ceramics, glass ceramics, single crystal ceramics, and zirconia ceramics have stable 
chemical properties[44]. Additionally, these inorganic implants can be further 
modified by some drugs to make them multifunctional. For example, Yao et al.[45] 
fabricated dexamethasone-loaded carbon nanotube (CNT), then they combined 
these nanoparticles with nano-hydroxyapatite/polyamide 66 porous scaffold to 
promote the differentiation of BMSCs into osteoblast.  
2.3. Organic scaffolds for drug-loading 
Most organic scaffolds are polymer scaffolds, according to the sources, these organic 
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scaffolds can be further divided into synthetic polymeric scaffolds, such as polylactic 
acid (PLA), polycaprolactone (PCL), and poly-L-lactide lactone, and natural polymeric 
scaffolds, like gelatin, HA, chitosan, and cellulose. 
2.3.1 Synthetic polymeric scaffolds for drug loading
Polyglycolic acid (PGA) is a biodegradable, thermoplastic polymer and the 
simplest linear, aliphatic polyester with a glass transition temperature between 35 
and 40 °C. The final degradation products of PGA are carbon dioxide and water, 
which can be eliminated by body metabolism. Usually, PGA fibers are particularly 
stiff with high strength and modulus (7 GPa) . This synthetic polymer has been widely 
used in fabricating internal fixation of fracture, scaffolds for bone regeneration and 
tendon repair, suture material, etc. Dehnavi et al. [46]prepared a novel conduit 
based on polymer blend nanocomposites of PGA, collagen, and nanobioglass were 
prepared by electrospinning technique, which can have potential for nerve 
regeneration. To treat intervertebral disc degenerative disease, Abbushi et al.[47] 
filled the defected intervertebral disc area with hybrid scaffold containing PGA and 
HA. This scaffold was proved can not only supply efficient mechanical strength to the 
local area, but also to accelerate tissue regeneration. 
Different from PGA’s poor degradability, PLA can be gradually degraded to lactic 
acid, which will be further adsorbed by the body. Generally, the degradation half-life 
of PLA is around half to two years. Additionally, due to the low glass transition 
temperature (around 65 C), PLA is also regarded as a candidate in researching shape 
memory polymer and 3D-printing technology. Due to these benefits, the applications 
of PLA in tissue engineering are explored by researchers. For example, Charlesharris 
et al.[48] investigated the capability of 3D porous scaffolds, containing PLA and 
calcium phosphate nanoparticles in mediating cell behaviors, during the process of 
bone regeneration. Chatzikyriakou et al.[49] fabricated composite materials by 
mixing PLA with β-tricalcium phosphate to promote skull repair. Thakur et al.[50] 
also dissolved lidocaine and mupirocin in the PLA solution, respectively. Then, they 
used double nozzle electrospinning technology to construct a complex fiber system, 
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in this system, every single fiber contained these two different drugs, respectively. In 
the drug release experiments in vitro, because of the different release characteristics 
between the two drugs, staged drug release was observed in this system. PLA is also 
easy to be modified with other chemical compounds, which makes it become a novel 
polymer material for scaffold fabrication. For example, Murakami et al.[51] modified 
the end of PEG-PLA block compound with aldehyde, using a Schiff base reaction with 
amino compound to form a hydrogel in 2 seconds, which leads to generate a 
hydrogel with tissue adhesion ability and provide a novel application strategy for 
tissue engineering. 
PCL is famous for soft texture, excellent extensibility and low temperature 
molding. This material has been regarded as carriers for controlling drug release, as 
scaffolds for culturing cells and tissues, and also surgical suture. For example, 
Louvrier et al. [52] evaluated the ability of DPSCs to colonize, proliferate and 
differentiate into functional odontoblast-like cells when cultured onto a 
polycaprolactone cone fabricated by jet-spraying and prototyped into a design 
similar to a gutta-percha cone. Alireza et al. [53]prepared a PCL/bioactive glass bone 
scaffold, they found that scaffolds sintered at 64.5°C for 100 min had optimal 
mechanical properties and 5 wt% scaffolds behaved closer to bone.
PLGA is an FDA approved medical polymer that can be applied as anti-adhesion 
film and excipient in controlling drug release. Liu et al. [54] prepared a highly porous 
PLGA scaffolds with interconnected pore structures and well orientated 
microtubules, then the surface of scaffold was modified with air plasma for 
simultaneously tackling the dimensional shrinkage of PLGA scaffolds and improving 
scaffold–tissue integration. To reduce acidification by degradation of PLGA, Park et 
al. [55]incorporated magnesium hydroxide nanoparticles into porous polymer 
scaffold, this implant was proved can not only to effectively neutralize the acidic 
hydrolysate but also to minimize the structural disturbance of scaffolds.
2.3.2 Natural polymer scaffolds for drug delivery
Natural polymer scaffolds have been broadly applied in clinical applications, because 
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of their abundant resources, excellent biocompatibility, biodegradability, low 
immunogenicity, and environmentally friendly. 
Collagen is one of the most important components in the extracellular matrix of 
cartilage tissues. Recently, collagen-alginate was used as bioink for three 
dimensional cell printing based cartilage tissue engineering[56]. Achilli et al.[57] 
investigated the influence of pH, ionic strength and temperature on the mechanical 
properties of collagen, further they designed a mechanical-controllable collagen 
hydrogel for vascular tissue engineering.
HA is a polymer polysaccharide consisting of glucuronic 
acid-N-acetylglucosamine disaccharide unit. HA widely distributes in various cell 
matrix and tissues. HA can be metabolized into glucosamine then fully absorbed by 
body. Taking advantage of this, Ehsan et al. [58] introduced an elastic, antimicrobial, 
and adhesive hydrogel comprised of methacrylated hyaluronic acid (MeHA) and an 
elastin-like polypeptide (ELP), which can be rapidly photo-cross-linked in situ for the 
regeneration and repair of different tissue. In addition, Kim et al.[59] fabricated a 
matrix metalloproteinase sensitive composite HA hydrogel by grafting two different 
peptides on HA, and then they cultured human mesenchymal stem cells on the 
surface of this hydrogel. As a result, these cells showed relatively high level in the 
expression of osteogenic related genes. 
Although, chitosan (CS) does not belong to the composition of human 
extracellular matrix, the structure and properties of CS are quite similar with amino 
dextran that is the main ingredient of extracellular matrix. In the area of tissue 
engineering, CS shows many advantages, such as outstanding biocompatibility, 
degradability, non-immunogenic, pyrogen-free reaction and ability in promoting 
wound healing. Based on abovementioned benefits, Frohbergh et al.[60] used 
electrospinning technology to fabricate an artificial periosteum that consisted of CS, 
hydroxyapatite and a natural bio-crosslinker Genipin. Co-culture this system with 
osteoblast, promising results were observed in the proliferation, differentiation and 
maturation of osteoblast. Recently, a biocomposite scaffolds containing chitosan 
(CS), nano-hydroxyapatite (nHAp) and nano-zirconium dioxide (nZrO2 ) along with 
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microRNA (miRNA) for bone tissue regeneration applications was reported [61]. 
Gelatin derives from partly degraded collagen in the connective tissue including skin, 
bones, muscle membrane, etc. These materials have been widely utilized in clinical 
treatments, due to their excellent biocompatibility and wide variety of sources. For 
example, Levett et al.[62] fabricated multifunctional scaffolds containing 
photo-crosslinking gelatin, HA and chondroitin sulfate to mimic the extracellular 
matrix for cartilage tissue engineering. Cheng et al.[63] also fabricated 
hydrogen-enhanced composite gelatin hydrogel modified with liposomes to deliver 
different types of drugs and promote bone regeneration, as shown in Figure 2.
2.3.3. Composite polymer scaffolds for drug delivery
Although, synthetic polymer scaffolds exhibit outstanding chemical stability, 
degradability, favorable mechanical property, controlled porosity and degradation 
rate, most of these materials are poor hydrophilicity with limited cell adhesion[64]. 
Moreover, the degradation products are usually acidic which can cause sterile 
inflammatory. And it is difficult to fully avoid solvent residue in synthetic scaffold, 
which will lead to a series of side effects in cells and causing inflammation and 
fibrosis in surrounding tissues. In contrast, a natural polymer usually has satisfactory 
biocompatibility and cytocompatibility. Furthermore, because these materials mainly 
derive from nature, the structure of a natural polymer is much similar with the main 
composition of the human extracellular matrix and the degradation production can 
be absorbed by human body. However, the short degradation period and 
unsatisfactory mechanical property limit the clinical application of some natural 
materials. Therefore, combining two or more different types of polymers which have 
complementary properties in a certain proportion will provide promising strategies 
in designing more favorable biomaterial-based scaffolds for clinical therapy. 
Many efforts have been done by researchers to achieve this goal, for example, 
Du et al. [65] fabricated a heparin sodium and VEGF co-loaded bionic 3D scaffolds 
with CS and PCL. Furthermore, they used this composite implant to prevent 
generating local thrombus around the vascular implant with small diameter and 
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promote the regeneration of vascular endothelial tissue in the local area, as shown 
in Figure 3. Dai et al. [66] constructed complex 3D scaffolds with controlled thickness 
by blending natural type I collagen with PLGA and applied it for the joint and 
cartilage tissue engineering. Kim et al. [67] utilized electrospinning to prepare 
scaffolds consisting of polyvinyl alcohol (PVA) and HA. Then these scaffolds’ cell 
adhesion abilities were investigated. Results indicated that this implant provide a 
suitable platform for cell culture and tissue engineering. Meng et al. [68] prepared 
PLGA/CS composite scaffolds with phenylbutyric acid by random and directed 
electrospinning, respectively. Then the effects of CS proportion and the influence of 
electrospinning methods on the properties of drug release in vitro were explored in 
these fibers. Results revealed that the drug release rate increased with the raising 
chitosan content, because the addition of chitosan enhanced the hydrophilicity of 
the PLGA/chitosan composite scaffold. Additionally, aligned fibers showed lower 
drug release rate than that of randomly oriented scaffolds. Zhu et al. [69] utilized 
PEG-b-PCL amphiphilic block copolymer micelles to carry adriamycin through 
hydrophobic interaction. Then these micelles were combined with cyclodextrin 
solution to prepare supramolecular composite hydrogel which showed potent 
inhibition ability to bladder cancer in vitro.                                       
2.4 Summary 
Various types of biomaterial scaffolds provide the foundation for carrying different 
drugs or combining with several drug carriers. For example, most of hydrophilic 
drugs can be easily combined with many natural polymer scaffolds, and in contrast, 
hydrophobic drugs tend to combine with synthetic materials, such as PLA, PCL, PLGA, 
etc. Moreover, drugs-loaded carriers can combine with many types of biomaterials 
scaffolds, which means that most of these drug carriers can be loaded into various 
scaffolds, making the necessary foundation for further clinical applications. 
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3 The application of scaffolds combined with liposomes in tissue 
engineering
As one of the FDA approved nanocarrier, during the last 30 years, liposomes have 
been investigated in diverse applications. Several properties are considered as main 
advantages to employ liposomes as drug carriers, such as satisfied biocompatibility, 
passive targeting ability, easily modified surface, etc. Due to these benefits, 
liposomes are combined with scaffold to make scaffold more functional, and at the 
same time, to take advantage from both sides and avoid drawbacks. For example, 
liposomes enable scaffold to have more choices in carrying drugs, regardless of the 
materials properties of the scaffolds. In addition, when liposomes are modified on 
the surface of implants or mixed into the matrix of scaffold, liposomes can be 
concentrated on the local area, which is difficult to achieve by intravenous injection. 
Scaffold is defined as a biomaterial structure that serves as a substrate and 
guide for tissue repair and regeneration, which means that not only bulk materials, 
like bare-metal stent or titanium stick, but also nanomaterials, such as nanoparticles, 
carbon nanotubes, can be regarded as a part in scaffolds. 
In this section, several types of scaffolds modified with liposomes are 
introduced to give an overview about how these composite systems function in 
treating diseases and their applications in tissue regeneration, are shown in Table 1. 
3.1. Metal scaffold combined with liposomes 
Metal scaffolds are mainly made of pure metal and alloy, which have excellent 
mechanical strength, toughness, anti-fatigue performance and outstanding 
conductivity in heat and electricity[70, 71]. However, these metal scaffolds have 
many limitations in meeting clinical demands, due to the simple functions. 
Therefore, recently, liposomes have been used to modify these metal scaffolds to 
meet the clinical requirements. For example, Antimisiaris et al.[72] modified nitinol 
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stents with dexamethasone-loaded liposomes, this complex system exhibited 50.84 
(± 5.48)% dexamethasone release in simulated urine after 48 h co-incubation. 
Additionally, no drug release can be observed in dry environment, which provides a 
novel strategy in controlling the drug release under the ureter environment. 
Different metal nanoparticles exhibit diverse characteristics that can be utilized in 
distinct applications. For example, TiO2 nanoparticles have photocatalytic 
performance, antibacterial ability and antitumor capability; Fe3O4 nanoparticles are 
usually used in performing magnetic resonance imaging, photothermal therapy, 
immunoassay and cell separation; and ZnO nanoparticles are frequently utilized in 
preparing biological sensors. Wang et al. [73] (Figure 4) modified liposomes with 
these three different metal nanoparticles to prepare a heterogeneous system that 
could be controlled by light, therefore this system can simultaneously deliver drug 
into the cell. Specifically, Rh-DOPC/TiO2 were internalized by endocytosis, 
Rh-DOPC/SiO2 and Rh-DOPC/Fe3O4 can also be internalized by HeLa cells. Some 
interesting phenomenon were also observed in this research, the phosphate in the 
lipid head group directly bonded with the metal oxide surface.  
3.2. Inorganic scaffold combined with liposomes 
Inorganic scaffolds usually consist of silicate, phosphate, borate, aluminate or 
sulfide, silicide, boride, phosphide, etc. Generally, most of the inorganic scaffolds, 
such as bioactive glass, hydroxyapatite, bio-inert ceramic, show favorable 
biocompatibility and acceptable mechanical strength. Moreover, these materials can 
also release some necessary elements to the surrounding environment in the 
process of tissue repair.
Wang et al.[74] (Figure 5) investigated different interaction between inverse 
phosphocholine lipids (CP) with TiO2 and SiO2, they found that CP can fuse with TiO2. 
In addition, this complex system showed higher stability that zwitterionic 
phosphocholine (PC) lipids PC/SiO2 system, which was indicated by washing the 
membrane under harsh conditions. Interestingly, the CP liposome cannot fuse with 
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silica surface because of a strong charge repulsion. 
This platform made the foundation for further investigations on combining 
inorganic materials with liposomes. The composite nanoparticles containing silica 
core and gold shell exhibit huge potential in treating cancer by photodynamic 
therapy. However, these nanoparticles show limited ability in carrying drugs, thus 
Wu et al.[75] utilized the excellent drug loading capability of liposomes to carry 
ariamycin. Furthermore, these nanoparticles were coated by silica and then by gold. 
This composite system took advantages of both chemotherapy and photothermal 
therapy to implement combination therapy to cancer. He et al.[76] connected 
phospholipid material with Fe3O4@SiO2 nanoparticles by covalent combination, then 
these materials were used to fabricate horseradish peroxidase-loaded liposomes. 
The generated liposomes can detect the presence of Cu2+ by naked eyes, providing a 
novel diagnostic strategy to clinical applications.  
3.3. Hydrogel combined with liposomes 
Hydrogel is a gel using water as a dispersion medium, which partly introduces some 
hydrophobic and hydrophilic groups to the crosslinked structure of the hydrophilic 
polymer, and the hydrophilic groups can interact with water molecules in the inner 
structure. In addition, these hydrophobic compositions can expand by combining the 
crosslinked polymers with water molecules. Because of the soft texture, excellent 
biocompatibility, and the ability in maintaining certain shape, these types of 
materials have been widely utilized in biomedical field. According to the source of 
materials, hydrogels are mainly divided into two types, synthetic polymeric 
hydrogels and natural polymeric hydrogels[77]. 
In general, synthetic polymer hydrogels are primarily consisting of polyacrylic 
acid, polyvinyl alcohol, polyacrylamide, etc., which have outstanding mechanical 
strength, excellent chemical stability, and clear composition. However, these 
materials still face some problems, such as poor biocompatibility and toxic 
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degradation productions. Different attempts are made to make these materials as 
excellent candidate for clinical applications. For example, Suri et al.[78] prepared 
unilamellar liposomes by solvent evaporation and rehydration. Then without any 
heating or chemical crosslinking, these liposomes were combined with PVA to 
fabricate composite hydrogel with the repeated freeze thawing to induce 
cross-linking. During the whole process of fabrication, any heating or chemical 
crosslinking was avoided, which makes sure the biocompatibility of this composite 
system, thus this material was promising to be a candidate for biomimetic sensing 
and implantable tissue applications. 
Kazakov et al.[79] modified N-octadecyl acrylamide on the surface of poly 
N-isopropylacrylamide-co-1-vinylimidazole hydrogel nanoparticles, then these 
hydrogel nanoparticles were heated above the phase transition temperature of 
liposomes. The integration between the hydrophobic chains of hydrogels and the 
phospholipid component of liposomes were observed by dynamic light scattering 
(DLS) and atomic force microscope (AFM). These hydrogel nanoparticles were 
covered into the inner phase of liposomes generating complex hydrogel 
nanoparticles coated with the phospholipid bilayer. These nanoparticles provided a 
novel platform to drug delivery and biophysical nanodevices. 
Mourtas et al.[80] tried to use phospholipids, hydrogenated lecithin, and 
cholesterol at different proportion to prepare small unilamellar vesicles and 
multi-compartment liposomes. Furthermore, these liposomes were mixed with 
carbomer 974 and hydroxyethyl cellulose to make different hydrogels, then these 
hydrogels were investigated by rheometer to explore their rheological properties. As 
shown by the results, liposome composition (membrane rigidity) and lipid 
concentration, but not liposome size, seem to be very important factors that 
determine the rheological modulations caused by liposome addition in gels. This 
work indicated that gel rheological properties may influence drug release kinetics, 
thus the implications of the liposomes on the final product rheological profile should 
be seriously considered. Gao et al.[81] utilized gold nanoparticles to modify the 
surface of liposomes, then these liposomes were further mixed with acrylamide, 
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ammonium persulfate, polyethylene glycol dimethacrylate, tetramethyl 
ethylenediamine at the room temperature for 4 h to obtain the complex hydrogels.
A pH-dependent fusion with bacterial membrane was observed in Staphylococcus 
aureus bacteria co-cultured with hydrogel formulation releasing 
nanoparticle-stabilized liposomes. When applying this material on the skin of 
Sprague Dawley (SD) rats, no significant skin toxicity was found after 7 days’ 
treatment, which indicated that this material could be a promising anti-bacterial 
scaffold in local area. 
Natural polymer hydrogels primarily involve collagen, gelation, HA, and CS. This 
type of hydrogel is famous for outstanding biocompatibility, and absorbable 
degradation products, which has been widely used in clinical treatment[82]. 
However, the mechanical strength and stability of those materials should be further 
improved to broaden the applications. Several efforts have been done to make those 
materials more suitable for clinical treatments. 
Gariepy et al.[83] firstly modified chitosan-β-glycerol with liposomes to make 
novel hydrogels. They found that liposomes can significantly improve the 
viscoelasticity and mechanical strength of this complex system. Moreover, CS can 
noticeably prolong the release time of hydrophilic drugs from 24 h to over two 
weeks in vitro. Lu et al.[84] connected aldehyde-modified xanthan gum with 
amine-modified liposome by dynamic Schiff base reactions to fabricate injectable 
self-healing hydrogel. Furthermore, MCF7 cells were cultured in this 3D scaffolds, 
which indicated that this system could be an intelligent carrier for cell therapy in 
tissue engineering. Li et al.[85] fabricated liposomes coated with thiolated-chitosan 
and maleated-chitosan, respectively. Then the two types of liposomes were 
combined with each other by thiol-olefin reactions, generating a chitosan/liposome 
composite hydrogel. the gel time and swelling ratio can be regulated by changing 
n-SH/n-C=C- ratio. After adding liposomes, the tensile strength of the gels increased, 
and the crystal became smaller. After culturing with HaCaT cell line, the hydrogel 
showed excellent biocompatibility in vitro, which indicated that this system could be 
regarded as drug-loaded scaffolds for tissue engineering. O'Neill et al.[86] blended 
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thermosensitive liposomes with thermosensitive chitosan hydrogels to prepare 
injectable thermosensitive composite chitosan hydrogels. After local injection and 
the stimulation of heating, the loaded drug deferoxamine was released from 
scaffolds to recruit stem cells and improve the expression level of VEGF, as shown in 
Figure 6. This responsive, local and specific release method provided a novel 
administration for tissue engineering.   
3.4. Electrospinning fibers combined with liposomes 
As an electrostatic stretching spinning method for polymer, first the polymer 
solution is incubated under static electricity at thousands or even tens thousands of 
volts and then under the action of electric field force, these charged droplets are 
accelerated at the Taylor cone apex of the capillary. When the electric field force is 
strong enough, these polymer droplets will overcome surface tension and form 
jetting stream. During the process of jetting, the solvent is evaporated, and the 
solidified stream is collected to obtain electrospinning fibers[87]. The diameters of 
electrospinning fibers are usually smaller than the size of cells, and in this case, these 
fibers can mimic the structure and biological function of natural extracellular 
matrix[88]. Most of human tissues and organs have similar form and structure of 
nanofibers, which makes the electrospinning fibers be popular in tissue engineering. 
Some polymer materials have outstanding biocompatibility and degradability, which 
could be regarded as favorable scaffolds. Moreover, electrospinning fibers own large 
specific surface areas and porosity, providing a suitable platform for further 
modifying or applications[89]. 
The electrospinning fibers are also often modified by liposomes, from surface 
modification, internal loading to self-assembly. For example, pre-electrospinning 
solvent was prepared by mixing liposomes solution with polymer solution, then 
electrospinning technology was utilized to fabricate composite fibers loaded with 
liposomes. The fibers can significantly prolong the drug release in liposomes. For 
examples, Li et al.[90] prepared naproxen-loaded liposomes with sodium 
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hyaluronate as stabilizer, then coaxial electrospinning technology was performed to 
fabricate fibers with core-shell structure. Liposomes were loaded in the core part to 
prolong the drug release period to up to two weeks. This material used as wound 
dressing could release analgesic for period in local area, which makes the treatment 
more efficiently. 
Lin et al. [91] mosaiced proteins into the membrane of liposomes to fabricate 
cinnamon essential oil/β-cyclodextrin loaded protein liposomes, then these 
liposomes were blended with polyethylene oxide to prepare novel fibers by 
electrospinning technology, as shown in the Figure 7. Because of the proteolysis, this 
fiber can release drug to kill certain bacillus cereus, providing a novel strategy to 
design an anti-bacterial material. Chandrawati et al.[92] prepared β-glucuronidase 
loaded liposomes, then they fabricated complex scaffolds by modifying PVA with 
these liposomes, the vitality of glucuronidase could be maintained for seven weeks. 
Moreover, prodrug SN-38-glucuronide could be successfully turned into 
antiproliferative drug SN-38 by this scaffold. After that, antiproliferative effect could 
be found in the human cervical cancer cells (HeLa) treated with biocatalytic 
electrospun fibers. The assembled biocatalytic materials successfully produced 
antiproliferative drugs, as is achieved by the current most successful cardiovascular 
stents on the market, and effectively suppressed proliferation of cells. Therefore, 
this platform could be a new idea to fabricate cardiovascular grafts. 
Liposomes with special functionality were grafted on the surface of 
electrospinning fibers though covalent bonds or non-covalent bonds. In this way, the 
drug is loaded in the liposomes instead of the scaffold, thus avoid the potential 
damage brought by high voltage electrostatic field during electrospinning. Monteiro 
et al.[93] processed the surface of CS fibers with some thiolation reagents, then 
gentamicin-loaded maleimide liposomes were grafted on the surface of fibers by 
covalent reactions, as shown in the Figure 8. In vitro experiments indicated that 
gentamicin released from the liposomes immobilized at the surface of 
electrospinning fibers has antibacterial activity against Escherichia coli, Pseudomonas 
aeruginosa and Staphylococcus aureus. Therefore, these results show that the 
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developed nanostructured delivery system has promising performance for wound 
dressing applications, and could be used in the eradication of these pathogens, 
which are a common cause of local infections Furthermore, they utilized thiolation 
reagents to treat the surface of polycaprolactone (PCL), then the 
dexamethasone-loaded liposomes were grafted on the surface of these PCL fibers 
through generating covalent bonds between maleimide and thiol. This scaffold could 
constantly release dexamethasone in the local area, promoting the osteogenic 
differentiation of human mesenchymal stem cells, which could be regarded as 
advanced drug carriers for controlling growth factors release. Batory et al.[94] 
fabricated nanogold, nanosilver and nanocopper-loaded liposomes. Then these 
liposomes were grafted on the surface of PCL fibers to produce composite fibers 
with the capability in anti-bacterial, antifungal, promoting the creation of collagen 
and elastin.
Another type of popular methods to fabricate composite fibers with liposomes 
is blending lipid materials with water-soluble polymer. When these composite fibers 
were dissolved in water, liposomes would be generated by self-assembly. Recently, 
this method has attracted wide attention from researchers, for example, 
polyvinylpyrrolidone (PVP) K60 and lecithin were utilized by Yu et al.[95] to make 
amphiphilic nanofibers. When these fibers were immersed into water, 
phosphatidylcholine liposome could be generated by self-assembly. Moreover, the 
diameter of liposomes could be controlled by regulating the proportion of lecithin. 
Liposomes generated by this method can provide strategies for developing 
multi-functional and novel drug carriers.
3.5. Summary
Although liposomes are usually as a liquid formulation, it could be combined with 
biomaterials in diverse types, such as hydrogel and electrospinning fibers to 
fabricate multifunctional composite systems. Associating liposomes with hydrogel 
can make composite system constantly release drug in the local area and supply 
efficiently mechanical support. Moreover, this hydrogel can also provide favorable 
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microenvironment to the cells in the local area. Combining liposomes with different 
types of electrospinning fibers provides some novel strategies to fabricate 
self-assembly drug delivery systems and also staged drug release systems. Therefore, 
the composite systems created by combining liposomes with various types of 
biomaterials are considered to be worth to translate into clinical applications.
4. The application of scaffolds combined with liposomes in disease 
treatment
In 1988, Swiss Cilag registered the econazole liposome gel to treat the skin diseases, 
which was the first liposome-based product, and now, this gel is sold in Switzerland, 
Italy, Belgium and other countries[96]. After that, various kinds of liposomes-based 
products were proposed, such as nystatin liposomes[97], hepatitis A vaccine 
liposomes[98], and cytarabine liposomes[99]. Some anti-cancer drug-loaded 
liposomes, anti-infection drug loaded liposomes and gene drug-loaded liposomes are 
under clinical trials. In addition, liposomes also exhibit promising characteristics in 
overcoming tumor resistance and biological barriers. Overall, these achievements in 
liposomes make the foundation for developing intelligent multifunctional 
liposomes-scaffold composed systems in treating various types of diseases, as shown 
in Table 2. 
4.1. Cancer therapy
Most of liposomes used for cancer therapy consist of the derivative of 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine- (polyethylene glycol) (DSPE-PEG). 
These materials can prevent liposomes from phagocytosis by mononuclear 
macrophage, leading to the prolonged circulation time and the increased 
accumulation in lesion. Thus, these liposomes are named as long-circulation 
liposomes. In cancer patient, the permeability of capillaries in lesion is increased, 
because of the inflammation and infection caused by the growth of solid tumor. 
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Therefore, nanoparticles with suitable diameter can go through capillaries and 
accumulate in the lesion, which is also known as passive targeting ability of 
liposomes. After some specific surface modifications like antibodies, hormones, 
sugars residue, receptor ligands, liposomes can show active cancer targeting ability, 
and additionally, liposomes can be designed to exhibit responses to some cancer 
relative or outside applied stimulations, such as pH, temperature, and magnetic 
field. Certain liposomes can also bring drugs to targeted organs, cells, or even 
subcellular organelles. All these characteristics of liposomes make them promised 
for designing composite liposomes scaffolds in cancer therapy. 
Mao et al. [100] prepared a thermosensitive injectable hydrogel containing 
paclitaxel-loaded liposomes, then the transform temperature, diameter, and drug 
release rate were investigated in vitro. Furthermore, the system was evaluated in a 
pancreatic cancer mice model and constant drug release and improved drug 
concentration was observed in the local area. Moreover, this system did not exhibit 
any significant toxicity to surrounding normal tissues. 
In another work, Xing et al.[101] combined 2-methoxyestradiol loaded 
liposomes with injectable thermosensitive PLGA-PEG-PLGA polymer to fabricate 
hydrogel with two-stage controlled drug release. In vivo experiments indicated that 
these liposomes could be transported to the local tumor area, improving the 
chemotherapy efficiency and bioavailability of the drug. In normal physiological 
conditions, 7-ethyl-10-hydroxycamptothecin (SN-38) could easily transform between 
active lactone form (SN-38A) to inactive carboxylic acid ester form (SN-38I) due to its 
low solubility. To solve this problem, Bai et al.[102] prepared acid SN-38 liposomes 
loaded in thermosensitive hydrogel, and after that, a series of experiments were 
carried out to explore the anticancer efficiency and biocompatibility of this 
composite systems. Usually, compound drug delivery systems contain organic 
nanocarriers and inorganic nanocarriers, and at the same time is expected to achieve 
its complementary advantages for the aim of improving the performance of 
antineoplastic drugs in cancer tumor therapy. 
Zhang et al.[103] modified gold nanoparticles with paclitaxel through covalent 
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bonds, and then the products were inserted into the bilayer of liposomes to 
construct a complex nanosystem. This system was utilized to treat mouse with liver 
cancer, and the pharmacokinetics, biodistribution, and anticancer efficiency were 
evaluated. The results indicated that integrated hybrid liposome had superior 
properties, including improved stability of the whole system, enhanced cellular 
uptake, and rapid-and-then-sustained drug release, resulting in enhanced tumor cell 
killing ability in vitro and tumor therapeutic efficacy in vivo.
4.2. Skin-related diseases
Skin is the biggest organ in human body, which consists of epidermis, dermis and 
subcutaneous tissue. The main functions of skin are to protect the body, feel 
temperature and pressure, and it can also protect various types of tissues and organs 
in body from the invasion created by pathogenic microorganism [104]. According to 
the features of skin, some researches try to fabricate some composite systems, 
which could meet the clinical demands. For example, paeonol is usually used to treat 
some skin-related disease, because it shows potential abilities in analgesia, 
anti-inflammatory, antipyretic and anti-allergic reactions[105]. But this drug has 
unsatisfactory solubility. Hydrogel is regarded as an ideal delivery carrier in the local 
area. To improve the solubility of paeonol, Xia et al.[106] fabricated paeonol-loaded 
liposomes. Then these liposomes were combined with hydrogel to enhance the local 
retention time and the affinity with the skin for achieving a better treatment effect. 
Adapalene (ADA) is the second generation of retinoic acid, exhibiting certain 
treatment effect in diverse skin diseases, such as acne vulgaris; however, this drug 
has dose-dependent side effects. To make this drug more suitable for clinical 
application, Jain et al. [107] prepared ADA-contained solid lipid nanoparticles, 
further these particles were combined with carbomer hydrogel to fabricate 
composite system. Then the drug release, biodistribution, skin penetration and 
rheology were investigated. The results indicated that this system can prevent ADA 
from systematically absorbing by skin, and release drug in local area, providing a 
 
 
 
Journal Pre-proof
27
novel strategy to treat hemorrhoids. Mandlik et al.[108] fabricated sertaconazole 
nitrate loaded liposomes with the diameter around 246.2 ± 2.49 nm and 
encapsulation efficiency of 86.16 ± 0.56 % by orthogonal test. Furthermore, these 
nanoparticles were blended with hydrogel. In this composite system, the percentage 
of drug spread was 13.24 %, and the deposition rate of drug in skin was 83.54 %. In 
vitro, antibacterial ring experiment indicated that the ring of this hydrogel was 33 
mm, which was significantly higher than 22 mm of the commercial materials, 
meaning that this novel material has stronger anti-bacterial activity.  
4.3. Diabetes
Type I diabetes, also known as insulin dependent diabetes, is one of the most 
popular disease in the world. To treat this disease effectively, Haque et al.[109] 
prepared a kind of injectable hydrogel containing isolated pancreatic islets and 
clodronate loaded liposomes at the same time, and then this hydrogel was utilized to 
treat SD rats without pancreatic islets. The results indicated that the hydrogel 
including isolated pancreatic islets and clodronate liposome, significantly enhanced 
the median survival time of SD rats for over 60 days. Furthermore, to solve a series 
of side effects, such as suffering brought by repeated injections, infection caused by 
wearing an insulin pump in catheter area, Chen et al.[110] developed a 
thermosensitive hydrogel modified with insulin-loaded liposomes to minimize the 
time of injection. By utilizing the theory that thermosensitive hydrogel could be 
liquid under low temperature and turn into gel at 37 C, hydrogel was formed in situ 
to constantly release insulin for 7 days to provide a strategy for diabetes treatment. 
4.4. Anti-inflammatory diseases
Inflammation is part of the complex biological response of body tissues to harmful 
stimuli, such as pathogens, damaged cells, or irritants, and is a protective response 
involving immune cells, blood vessels, and molecular mediators. Additionally, the 
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main symptoms of inflammation are red, swelling, fever, pain and disfunction[111]. 
In the process of inflammation, on one hand, the endogenous damaging factors 
directly or indirectly destroy tissues and cells, and on the other hand, the factors are 
diluted and inactivated by exudation and congestion caused by inflammation[112]. 
At the same time, the regeneration of parenchymal cells and interstitial cells leads to 
tissue repair and healing, therefore inflammation is considered as an incorporate 
process, including both damage and anti-damage. Scaffolds combined with 
liposomes have also been used for anti-inflammatory. 
For example, Negi et al.[113] fabricated resveratrol-loaded liposomes by taking 
advantage of both ethanol injection and film dispersion method, then these 
liposomes were further processed with a hydrogel. The generated hydrogel system 
was confirmed to follow Korsmeyer-Peppas model in different drug release condition 
in vitro. Especially, in the model of swelling mouse paw induced by carrageenan, this 
system could significantly prolong the treatment time and reduce the extent of 
swelling in vitro, compared with standard diclofenac sodium gel. Furthermore, 
resveratrol also showed higher permeability and deposition in skin. 
4.5. Human immunodeficiency virus (HIV)
HIV is a virus that can cause defect in human immune system and mainly attack 
human helper T lymphocyte system. Once, this virus irrupts human cells, it will 
integrate with the normal cells, thus it is extremely difficult to eliminate this virus. 
Moreover, this virus infection induced high mortality rate and long incubation period 
[114]. A composite system was fabricated by Ramanathan et al.[115] using hydrogel 
as a core structure and a phospholipid bilayer as shell structure to carry maraviroc 
and tenofovir disoproxil fumarate. This system was applied in the treatment of HIV in 
mouse by absorbing in mouse vaginal mucosa, leading to antiviral activity against 
HIV-1 BaL in cervicovaginal lavages.
4.6. Anti-bacterial applications
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Bacterial infection leads to a series of symptoms in patients like long lasting fever, 
headache, nausea, and vomiting [116]. Thus, it is meaningful to investigate 
anti-bacterial treatment in order to get better recovery in patients. Specifically, 
chitosan hydrogel was combined with mupirocin-loaded liposomes to build complex 
hydrogel system, then the biocompatibility and anti-bacterial capability of this 
hydrogel were explored in vitro, and mouse burn model was utilized to evaluate the 
potential ability of hydrogel in vivo. As shown by the results, the delivery system 
enhanced wound healing and was equally potent as the marketed product of 
mupirocin[117]. 
4.7. Summary
Advanced scaffolds modified with liposomes were applied in various types of areas, 
such as tumor, skin disease, diabetes, inflammation, HIV and infection. Moreover, 
these applications exhibit some benefits due to special properties of scaffolds, such 
as mechanical supporting, 3D structure and therapy functions brought by 
drug-loaded liposomes, such as anti-cancer, antibacterial, and anti-inflammation. 
However, these materials also meet some challenges in application, for example, 
some local inflammation could be caused by implanted scaffolds; under the physical 
conditions, the drug release behavior could be different from the lab testing. Making 
the properties of composite scaffolds closer to the original tissues or organs could be 
a promising strategy for these materials. 
5. The application of scaffolds modified with liposomes in tissue 
regeneration 
5.1. Bone regeneration 
During bone regeneration there is stimulation of various kind of cytokines, 
osteogenic precursor cells, including osteoblasts and osteoclasts are activated. 
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Firstly, these cells are involved in the process of bone resorption, specifically 
osteogenic precursor cells are attracted to the site of bone resorption, then 
proliferation of pre-osteoblasts can be observed under the effect of diverse 
cytokines. Furthermore, these pre-osteoblasts differentiate to mature osteoblasts 
that can combine with osteogenic proteins, including type I collagen, osteocalcin, 
alkaline phosphatase, glycoprotein, and growth factors to generate matrix 
mineralization. Because of the effect of cytokines, some morphological changes 
happen in osteoblasts, leading to the drop of these cells from the surface of bone, 
then the circulating osteoclasts can attach through the bone surface, triggering the 
process of bone resorption. During this process, the osteoblasts surrounding 
osteoclasts also take part in bone resorption by decomposing the collagen in the 
bone lacuna. After that, the remained components and generated cytokines can act 
on osteoclasts to induce the bone generation. Many types of cytokines take part in 
regulating the process of bone regeneration[118]. In addition, the mechanical 
properties of the whole system can be influenced by bone defect, because the lack 
of mechanical supporting and 3D environment would cause the decrease in cell 
proliferation, attachment and differentiation in the local defect area[119]. Therefore, 
composite scaffolds, which can release drug in situ for long-term and fill the defect 
area will provide certain mechanical support for the entire system, have promising 
prospect in clinical applications.
The nanofibers structure of bone proteins was mimicked by poly PLA nanofibers 
(by Mohammadi et al.[120]), then these fibers were coated with hydroxyapatite 
nanoparticles to simulate bone mineralization. Furthermore, bone morphogenetic 
protein-2 peptide loaded liposomes were grafted on the scaffolds by covalent bond 
to regulate the release rate of peptides. As shown in Figure 9 favorable 
biocompatibility and satisfactory ability in promoting the osteogenic differentiation 
of MSC can be observed in this scaffold. In another work, non-phospholipid liposome 
was fabricated by Cui et al.[121] by using bipolar single-chain molecule with high 
sterol content. Moreover, hydroxycholesterol was proved to have the capability in 
stimulating bone formation, thus 20(S)-hydroxycholesterol was used as a 
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composition in the liposomes. Furthermore, the cytocompatibility and osteogenic 
capacity of this liposomes were proved by combining this nanomaterial with 
hydrogel in vitro, which provides a novel administration strategy that 
non-phospholipid liposome is regarded as a platform for delivering small drug 
molecules or genes to promote bone regeneration. Deferoxamine (DFO) is a small 
molecule hydrophilic drug that can upregulate the expression of hypoxia-inducible 
factor 1-α ) (HIF-1α ) and VEGF in bone and serum to enhance the angiogenesis in 
bone. Additionally, the high expression of osteogenic related proteins in the Wnt 
signal pathway further accelerating the bone formation. However, because of high 
hydrophilicity, it is challenging for this drug to maintain effective concentration in 
the local area. Thus, Chen et al.[122] fabricated DFO-loaded liposomes and modified 
gelatin methacryloyl (GelMA) with these liposomes to release drug in situ for 
long-term, promoting the angiogenesis and bone regeneration.
5.2. Wound healing 
Wound healing is a recovery process after defect or disconnect occurs in skin or 
other related tissues. This process mainly includes the regeneration of various tissue 
(including epidermis and dermis), the proliferation of granulation tissue and the 
formation of scar tissue, where diverse synergy effects can be found in this 
process[123]. At the same time, angiogenesis, inflammation and anti-infection play 
important roles in wound healing. 
Using traditional anti-infection methods to treat partial thickness burns cannot 
provide humid environment to promote wound healing. Therefore, Homann et al. 
[124] took advantage of liposomes-modified polyvinylpyrrolidone-iodine hydrogel to 
treat 43 randomly selected patients with second degree burn wound. The patients 
treated with commercial sulfa silver ointment were regarded as control groups. The 
results indicated that patients handled with hydrogel had better prognostic, because 
higher water binding rate was found in the composite hydrogel system, which could 
provide necessary humidity to the defect area. Moreover, it was much easier to 
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change the hydrogel dressing, which caused less injury on the burn wound. 
Fibroblast growth factors (FGF) play vital roles in the routing of the wound 
healing, because they show ability in promoting the migration of endothelial cells 
and the proliferation of smooth muscle cells. Additionally, it can also accelerate the 
formation of new blood vessel and repair damaged endothelial cells. Therefore, how 
to maintain the effective concentration of FGF on the wound area with lots of wound 
leachate is a key factor in the process of treating wounds. Basic fibroblast growth 
factors (bFGF) loaded-silk fibroin hydrogel was embed into the inner phase in 
liposomes by Xu et al.[125], and then superior capability in controlling release of 
bFGF and also promoting bFGF penetration was observed in this complex system. 
This platform could be regarded as an excellent carrier to deliver growth factors to 
the wound area.
Wound, especially burn wound, tends to cause life threatens to patients, 
because of infection. But, the risk of wound infection can be decreased in a 
long-term by administrating enough antibiotic in the local wound area. Specifically, 
mupirocin was utilized as a model drug by Hurler et al.[126] to make drug-loaded 
liposomes. Then composite system was fabricated by mixing these liposomes with 
chitosan hydrogel, which exhibited significant longer duration of drug release both in 
vivo and in vitro. Additionally, drug release rate was regulated by controlling the 
diameter of liposomes. Noticeable inhibition effect on staphylococcus aureus and 
bacillus subtilis was observed. Moreover, comparing with commercial mupirocin 
cream, this system showed more powerful capability in antibacterial and 
bio-adhesion. 
5.3. Spinal cord repairment
Permanent functional defect will be caused by spinal cord injury, including neuronal 
and axonal damage; moreover, the regeneration ability of spinal cord is limited, 
therefore it is still a big challenge to treat spinal cord injury in clinic [127]. Recently, 
neural stem cells (NSCs) are gradually regarded as cellular sources for spinal cord 
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regeneration, because those cells exhibit potential ability in differentiating into 
neurons, astrocytes and oligodendrocytes, and then establishing connection with 
host cells [128]. However, because of the limits brought by local microenvironment, 
most of these neural stem cells tend to differentiate into astrocytes or 
oligodendrocytes instead of neurons. Therefore, it is meaningful to induce these 
neural stem cells to differentiate into neurons for spinal cord regeneration. 
According to reports, after spinal cord injury, microtubule-stabilizing agent 
paclitaxel (MSPTX) could reduce the generation of scar and enhance the 
regeneration of inner axon. Thus, a composite collagen microwell scaffold containing 
MSPTX-loaded liposomes and neural stem cells was fabricated by Li et al.[129]. The 
PTX functionalized collagen scaffolds could not only alleviate myelin inhibition, but 
also enhance intrinsic neuronal differentiation potential of NSCs in vitro. 
Furthermore, this scaffold was implanted into the T8 transverse part of mouse spinal 
cord, as shown in Figure 10. The functional scaffolds could provide an instructive 
microenvironment for NSCs to differentiate into mature neurons and functional 
sensory and motor neurons. Together, this scaffold provided a suitable 
microenvironment for the differentiation of neural stem cells, the regeneration of 
motor neurons and sensory neurons, the attendance of axon, making improvements 
in the motor evoked potentials and hindlimb movement. 
5.4. Teeth regeneration
Currently, the life spans of dental restorations are relatively short. Therefore, 
utilizing tissue engineering to promote the regeneration of dentin pulp complex 
means a lot to the successful implant of dental restorations. There are plenty of 
bioactive factors and extracellular matrix proteins that are related with the 
recruitment, proliferation and differentiation of pulp progenitor cells in dentin 
matrix. Therefore, Melling et al.[130] fabricated decalcified dental matrix loaded 
liposomes (DDM-Lip) to repair the teeth tissues. As the results showed, more 
efficiency in recruiting and activating dental pulp stem cell (DPSC) could be found in 
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samples treated with DDM-Lip, comparing to samples treated with DDM. Moreover, 
the recruitment and activity of DPSC are necessary factors in the process of teeth 
tissues regeneration. This research proved the potential capability of DDM-Lip in 
stimulating teeth regeneration in vitro, which supply a novel strategy for teeth repair 
and hard tissue engineering. 
5.5. Summary 
The smart composite scaffolds modified with liposomes are widely utilized in the 
tissue regeneration, because of its favorable biocompatibility, and controlled drug 
release in situ, as shown in Figure 3. Moreover, it can also provide sufficiently 
mechanical support to the defect area and suitable microenvironment for the cells’ 
adhesion and proliferation. During the process of tissue regeneration, regulating 
cytokines and promoting differentiation of cells play important roles. Thus, to 
broaden the application of composite scaffolds in tissue regeneration, some 
modification could be processed in lecithin, which is the major composition for 
liposomes. For example, taking advantages of both liposomes and proteins from the 
cell membrane, different types of cytokine-loaded liposomes could be modified with 
diverse cell membrane, and further combined with scaffold to construct novel 
composite implant, which is more suitable for clinical applications.
6. Conclusion and further perspectives
Liposomes are nanocarriers that can maintain drugs in the lipid bilayer and inner 
core. The inner part of the carriers can be used to load some hydrophilic drugs, such 
as small molecules or macromolecules like proteins, antibodies, and cytokines. At 
the same time, some lipid drugs can be carried on the bilayer to achieve the goal of 
co-delivery drugs with different characteristics. As drug carriers, liposomes exhibit 
many advantages, such as lymphatic system tropism, passive targeting on bone 
marrow and spleen, excellent ability in controlling drug release, reducing drugs side 
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effects, and improving the stability of drug. However, liposomes still face some 
challenges, for example, the liposomes have some troubles in transporting and store 
drugs. Moreover, it is difficult for liposomes to maintain certain drug concentrations 
in the local area for long periods of time. Therefore, to make liposomes more 
suitable for the clinical applications, these disadvantages should be solved without 
compromising their advantage properties.
Scaffolds have attracted wide attention from the researchers, because they can 
be used in diagnosis, repairment or enhancement of human tissues or organs. 
Moreover, they own unique functions that cannot be replaced by drugs. Although, 
certain mechanical supporting and suitable microenvironment for proliferation can 
be supplied by scaffolds in situ and scaffolds can control the flow of blood and body 
fluid, their ability to recover the defect is weak. Thus, further functionalization is 
needed for scaffolds in order to broaden their applications in clinic. 
Fabricating composite scaffolds combined with liposomes cannot only provide 
scaffolds with the ability to promote regeneration and treating diseases, but also 
maintain the drug concentration in situ for a long period of time. Additionally, 
scaffolds modified with liposomes showed sustained drug release. Furthermore, 
uniform liposome solution with different types of drugs can be easily formed, which 
can be used to distribute drugs evenly in the scaffold. By this method, liposome 
composite scaffolds can deliver diverse medicines and achieve the goal of synergistic 
therapy. 
Favorable combination between liposomes and scaffolds can be obtained by 
adjusting the composition of the phospholipid bilayer to avoid the generation of 
interface separation. Moreover, significantly mechanical enhancement of the 
composite scaffolds can be achieved by regulating the covalent bonds or 
non-covalent bonds between liposomes and scaffolds. 
Currently, a series of achievements have been obtained by this composite 
system, for example, in the tumor resection model, the continued drug release 
shows an inhibition effect on residual tumor. Additionally, the implant supplies 
suitable microenvironment for the cells’ adhesion and proliferation so that 
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satisfactory effects in anti-tumor and promoting tissue regeneration are observed. 
However, for the composite system, there are still some challenges, for example, 
when the drug is delivered by this method, it will be difficult to calculate and give the 
specific dosage to the patients or experimental animal. Because the drug is firstly 
loaded into liposomes, then the drug-loaded liposomes are further combined with 
different scaffolds, during the whole process the loaded-drug can leak out of the 
system. In the bone defect area, scaffolds can provide certain mechanical 
supporting, and at the same time, liposomes can accelerate the osteogenic 
differentiation by controlling drug release in situ. Some potential issues can cause 
problems in this application, for example, the degradation period of scaffold cannot 
match with the regeneration rate of bone, then the newborn bone will cover the 
scaffold, finally the remained implants could hinder the bone regeneration. In the 
wound healing applications, dressings are usually regarded as an anti-infecting 
physical barrier, which can provide suitable humidity and regeneration environment 
to the wound, meanwhile, the continuously released antibacterial drugs can play an 
anti-infective role. Sometimes, the infected area consists of not one type bacterium, 
but different kinds of bacteria Thus, if the loaded drug cannot meet the demand to 
clear all these bacteria, then the surviving bacterium can be resistant to the 
following treatment. 
Based on some current novel researches, the following liposome-scaffold 
system can be the future research trend. Specifically, (1) liposome-scaffold, including 
diagnosis, imaging and therapy in one composite system; (2). liposomes fused with 
different kind of cell membranes, according to the clinical demands, then combine 
with scaffolds to treat diseases and accelerate tissues repairment by taking the 
advantage of the immune therapy and tissues engineering; and (3) self-assembly 
drug delivery systems and staged responsive delivery systems fabricated by 
combining scaffolds and liposomes would provide promising prospects to disease 
treatment and tissue regeneration.             
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Figure 1. (A) Scheme of inorganic strengthened hydrogel membrane for regenerative 
periosteum. (B) Progress of fabricating methacrylic acid modified gelatin, amino 
modified MBGNs and GelMA-MBGNs(G-MBGNs) and preparing GelMA/MBGNs and 
GelMA-G-MBGNs. (C) Regenerative periosteum utilized in treating calvarial 
critical-sized defects in Sprague Dawley rats. Reprinted with permission from ref. 
[49]. 
 
 
 
Journal Pre-proof
48
Figure 2. Scheme of mechanically enhanced lipo-hydrogel with controlled release of 
multi-type drugs for bone regeneration. 
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Figure 3. (A) Schematic diagram of gradient and uniform nano-fibrous scaffolds for 
vascular tissue regeneration. (B) The proliferation of human umbilical vein 
endothelial cells (HUVECs) on the nanofibrous scaffolds with different formulation i 
by MTT assay. (C) Fluorescent images of cross-section of sandwich cell-scaffold-cell 
structure. Reprinted with permission from ref. [65].
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Figure 4. (A) Hybrid nanostructure formed using the oxides and DOPC liposomes. 
SiO2 NPs form supported bilayers, while the other oxides are adsorbed. TiO2 is a 
photocatalyst. (B) Chemical structure of the DOPC lipid. (C) Rh-DOPC liposome 
adsorption by the oxides indicated by the different supernatant fluorescence 
intensity. (D) The mass of DOPC associated with 100 μg of TiO2 or SiO2 NPs as a 
function of NaCl concentration. (E) Photographs of Rh-labeled DOPC liposome 
interacting with TiO2 NPs as a function of pH. (F) Scheme of protonation of TiO2, 
affecting its surface charge. (G) Quantification of DOPC adsorption by various oxides 
as a function of Ph. (H) ζ-potential as a function of pH for the oxides. Reprinted with 
permission from ref. [85].
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Figure 5. (A) Schematics of DOPC liposome adsorption by TiO2 NPs and DOCP 
liposome forming supported bilayers. (B) Photographs of the supernatants of the 
Rh-labeled DOPC, DOCP, and DOCPe liposomes mixing with TiO2 NPs at various pH 
values and after centrifugation. (C) Quantitative analysis non-adsorbed liposomes by 
TiO2 as a function of pH. Reprinted with permission from ref. [86].
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Figure 6. (A) Picture of heating set-up showing the chitosan hydrogel in the water 
bath and agar gel thermally insulated. (B) coronal temperature maps showing the 
temperature changes in the chitosan gel at 3 min increments. (C) Absolute DFO 
release from Lipogel in response to increased durations of hyperthermia. (D) DFO 
release (100 μM) from chitosan/b-GP gels containing liposomal DFO at 37 C after a 
repeated hyperthermic pulse of 1, 3, 10 or 30 min. (E) Mixed pulse Lipogel permitted 
multiple DFO doses by increasing the duration of hyperthermia every 24 h (red 
arrow) (1, 3, 10, and 30 min). Reprinted with permission from ref. [98].
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Figure 7. (A) Schematic of electrospinning for CEO/β-CD proteoliposomes 
incorporated into PEO nanofibers. And schematic of B. cereus proteinase-triggered 
CEO release from CEO/β-CD proteoliposomes. (B) The SEM-micrographs of pure PEO 
nanofibers and CEO/β-CD proteoliposomes nanofibers. (C) Diameter distribution of 
pure PEO nanofibers and CEO/β-CD proteoliposomes nanofibers. (D) The release rate 
of CEO/β-CD proteoliposomes nanofibers stored at different temperature. Reprinted 
with permission from ref. [103].
 
 
 
Journal Pre-proof
54
Figure 8. (A) Chemical pathway for the immobilization of liposomes on the surface of 
Ch NFM. (B) SEM results and EDS spectrum of immobilized Gent-loaded liposomes at 
the surface of electrospun Ch NFMs. (C) In vitro cumulative release of gentamicin 
from Ch nanofibers immersed in gentamicin solution, gentamicin release from 
liposomes in suspension and immobilized at the surface of one electrospun Ch NFM. 
(D) In vitro antibacterial activity of the corresponding blank control, gentamicin 
control, electrospun Ch NFM, Gent free liposomes immobilized electrospun Ch NFM, 
and Gent-loaded liposomes immobilized electrospun Ch NFM against S. aureus, E. 
coli, and P. aeruginosa assessed by the different assay methods. Reprinted with 
permission from ref. [105].
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Figure 9. A brief summary illustrating functionalization of the scaffold platform and 
immobilization of BMP-2 peptide loaded liposomes on to the scaffold to fabricate 
bone-graft mimicking scaffold for bone tissue engineering. Reprinted with 
permission from ref. [134].
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Figure 10. (A) Schematic illustration of a collagen scaffold carrying PTX-liposomes. (B) 
AFM image of PTX-liposomes. (C) Particle size and particle size distribution of 
PTX-liposomes. (D, E) SEM images of collagen scaffolds showing the (D) longitudinal 
and (E) transverse morphologies. (F) Cumulative release profiles of PTX-liposome 
loaded collagen scaffolds in PBS containing 1.0M sodium salicylate at 37 °C 
compared with pristine PTX. (G) Design of in vitro study and in vivo transplantation at 
T8 complete transection of rat spinal cord. (H) Representative images of Tuj-1 
immunostaining of NSCs cultured on (a) collagen scaffold, and collagen scaffolds 
carrying varied dose of PTX-liposomes (b) 0.85 (1×), (c) 4.25 (5×), and (d) 8.50 ng/mL 
(10×). (I) Quantification of neuronal differentiation rates. Reprinted with permission 
from ref. [143].
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Table 1. The fabrication methods of different platforms modified with liposomes.
Platform (modified with liposomes) Fabrication methods Ref.
Surface modification [74] [75]
Mental scaffold
Coating [75]
Surface modification [76] [78]
Inorganic scaffold
Coating [76] [77]
Coating [91] [96]
Hydrogel
Mixing [80][82][83][85] [88]
Surface modification [93] [94]
Internal loading [90][91][92]Electrospinning fibers
Self-assembly [95]
Table 2. The functions of diverse platforms modified with liposomes in treating 
diseases. 
Disease treatment Platform (modified with liposomes) Ref.
Hydrogel [100] [101] [102]
Cancer Therapy 
Mental scaffold [103]
Skin disease Hydrogel [106] [107] [108]
Diabetes Hydrogel [109] [110]
Inflammation Hydrogel [113]
HIV Hydrogel [115]
Infection Hydrogel [117]
Table 3. The functions of different types of platforms modified with liposomes in 
tissue regeneration. 
Tissue 
regeneration
Platform (modified with liposomes) Ref. 
Electrospinning fibers [120] 
Bone 
Hydrogel [121] [122]
Wound healing Hydrogel [124] [125] [126]
Spinal cord Collagen fibers [129]
Teeth Demineralized dentin matrix [130]
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